Comparative analysis of novel transgenic mouse models for brain and islet amyloidoses

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/512484

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We aim to understand what two highly prevalent diseases, the brain disorder Alzheimer's disease (AD) and the metabolic disorder Type 2 Diabetes mellitus (DM), have in common. Through understanding pathogenesis and the development of novel transgenic models our long-term research goal is to identify new drug targets, to develop screening assays and to patent new findings. Collectively, this hopefully leads to AD and DM drugs and reduces the socio-economic burden of both debilitating diseases.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $468,119.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical infection agents (incl. prions)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Ageing | Alzheimer | Alzheimer's disease | Dementia | Diabetes | Obesity | amyloid | animal model | insulin resistance | type 2 diabetes

Related Links